<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ClinVarVariationRelease xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
                         xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/clinvar_variation/variation_archive_1.4.xsd"
                         ReleaseDate="2019-12-31">
    <VariationArchive VariationID="476472" VariationName="NM_001849.3(COL6A2):c.2697G&gt;A (p.Thr899=)"
                      VariationType="single nucleotide variant" DateCreated="2017-12-20" DateLastUpdated="2020-06-05"
                      Accession="VCV000476472" Version="4" RecordType="interpreted" NumberOfSubmissions="3"
                      NumberOfSubmitters="3">
        <RecordStatus>current</RecordStatus>
        <Species>Homo sapiens</Species>
        <InterpretedRecord>
            <SimpleAllele AlleleID="470827" VariationID="476472">
                <GeneList>
                    <Gene Symbol="COL6A2" FullName="collagen type VI alpha 2 chain" GeneID="1292" HGNC_ID="HGNC:2212"
                          Source="submitted" RelationshipType="within single gene">
                        <Location>
                            <CytogeneticLocation>21q22.3</CytogeneticLocation>
                            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38"
                                              AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46098071"
                                              stop="46132849" display_start="46098071" display_stop="46132849"
                                              Strand="+"/>
                            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25"
                                              AssemblyStatus="previous" Chr="21" Accession="NC_000021.8"
                                              start="47518032" stop="47552762" display_start="47518032"
                                              display_stop="47552762" Strand="+"/>
                        </Location>
                        <OMIM>120240</OMIM>
                    </Gene>
                </GeneList>
                <Name>NM_001849.3(COL6A2):c.2697G&gt;A (p.Thr899=)</Name>
                <CanonicalSPDI>NC_000021.9:46132188:G:A</CanonicalSPDI>
                <VariantType>single nucleotide variant</VariantType>
                <Location>
                    <CytogeneticLocation>21q22.3</CytogeneticLocation>
                    <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true"
                                      AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46132189"
                                      stop="46132189" display_start="46132189" display_stop="46132189" variantLength="1"
                                      positionVCF="46132189" referenceAlleleVCF="G" alternateAlleleVCF="A"/>
                    <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25"
                                      AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47552103"
                                      stop="47552103" display_start="47552103" display_stop="47552103" variantLength="1"
                                      positionVCF="47552103" referenceAlleleVCF="G" alternateAlleleVCF="A"/>
                </Location>
                <HGVSlist>
                    <HGVS Assembly="GRCh37" Type="genomic, top-level">
                        <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021"
                                              sequenceVersion="8" change="g.47552103G&gt;A" Assembly="GRCh37">
                            <Expression>NC_000021.8:g.47552103G&gt;A</Expression>
                        </NucleotideExpression>
                    </HGVS>
                    <HGVS Assembly="GRCh38" Type="genomic, top-level">
                        <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021"
                                              sequenceVersion="9" change="g.46132189G&gt;A" Assembly="GRCh38">
                            <Expression>NC_000021.9:g.46132189G&gt;A</Expression>
                        </NucleotideExpression>
                    </HGVS>
                    <HGVS Type="coding">
                        <NucleotideExpression sequenceAccessionVersion="NM_001849.3" sequenceAccession="NM_001849"
                                              sequenceVersion="3" change="c.2697G&gt;A">
                            <Expression>NM_001849.3:c.2697G&gt;A</Expression>
                        </NucleotideExpression>
                        <ProteinExpression sequenceAccessionVersion="NP_001840.3" sequenceAccession="NP_001840"
                                           sequenceVersion="3" change="p.Thr899=">
                            <Expression>NP_001840.3:p.Thr899=</Expression>
                        </ProteinExpression>
                        <MolecularConsequence ID="SO:0001819" Type="synonymous variant" DB="SO"/>
                    </HGVS>
                    <HGVS Type="coding">
                        <NucleotideExpression sequenceAccessionVersion="LRG_476t1" sequenceAccession="LRG_476t1"
                                              change="c.2697G&gt;A">
                            <Expression>LRG_476t1:c.2697G&gt;A</Expression>
                        </NucleotideExpression>
                        <ProteinExpression sequenceAccessionVersion="LRG_476p1" sequenceAccession="LRG_476p1"
                                           change="p.Thr899=">
                            <Expression>LRG_476p1:p.Thr899=</Expression>
                        </ProteinExpression>
                    </HGVS>
                    <HGVS Type="genomic">
                        <NucleotideExpression sequenceAccessionVersion="NG_008675.1" sequenceAccession="NG_008675"
                                              sequenceVersion="1" change="g.39071G&gt;A">
                            <Expression>NG_008675.1:g.39071G&gt;A</Expression>
                        </NucleotideExpression>
                    </HGVS>
                    <HGVS Type="genomic">
                        <NucleotideExpression sequenceAccessionVersion="LRG_476" sequenceAccession="LRG_476"
                                              change="g.39071G&gt;A">
                            <Expression>LRG_476:g.39071G&gt;A</Expression>
                        </NucleotideExpression>
                    </HGVS>
                </HGVSlist>
                <XRefList>
                    <XRef ID="CA10072979" DB="ClinGen"/>
                    <XRef Type="rs" ID="11554669" DB="dbSNP"/>
                </XRefList>
                <AlleleFrequencyList>
                    <AlleleFrequency Value="0.00010" Source="Trans-Omics for Precision Medicine (TOPMed)"/>
                </AlleleFrequencyList>
                <GlobalMinorAlleleFrequency Value="0.01697" Source="1000 Genomes Project" MinorAllele="T"/>
            </SimpleAllele>
            <ReviewStatus>criteria provided, conflicting interpretations</ReviewStatus>
            <RCVList>
                <RCVAccession Title="NM_001849.3(COL6A2):c.2697G&gt;A (p.Thr899=) AND Bethlem myopathy 1"
                              DateLastEvaluated="2019-12-31" ReviewStatus="criteria provided, single submitter"
                              Interpretation="Likely benign" SubmissionCount="1" Accession="RCV000546795" Version="3">
                    <InterpretedConditionList TraitSetID="5661">
                        <InterpretedCondition DB="MedGen" ID="CN029274">Bethlem myopathy 1</InterpretedCondition>
                    </InterpretedConditionList>
                </RCVAccession>
                <RCVAccession Title="NM_001849.3(COL6A2):c.2697G&gt;A (p.Thr899=) AND not specified"
                              DateLastEvaluated="2017-09-11" ReviewStatus="criteria provided, single submitter"
                              Interpretation="Likely benign" SubmissionCount="1" Accession="RCV000609723" Version="1">
                    <InterpretedConditionList TraitSetID="9590">
                        <InterpretedCondition DB="MedGen" ID="CN169374">not specified</InterpretedCondition>
                    </InterpretedConditionList>
                </RCVAccession>
                <RCVAccession Title="NM_001849.3(COL6A2):c.2697G&gt;A (p.Thr899=) AND Collagen VI-related myopathy"
                              DateLastEvaluated="2018-01-15" ReviewStatus="criteria provided, single submitter"
                              Interpretation="Uncertain significance" SubmissionCount="1" Accession="RCV001143621"
                              Version="1">
                    <InterpretedConditionList TraitSetID="7429">
                        <InterpretedCondition DB="MedGen" ID="CN117976">Collagen VI-related myopathy
                        </InterpretedCondition>
                    </InterpretedConditionList>
                </RCVAccession>
            </RCVList>
            <Interpretations>
                <Interpretation DateLastEvaluated="2019-12-31" NumberOfSubmissions="3" NumberOfSubmitters="3"
                                Type="Clinical significance">
                    <Description>Conflicting interpretations of pathogenicity</Description>
                    <Explanation DataSource="ClinVar" Type="public">Likely benign(2);Uncertain significance(1)
                    </Explanation>
                    <Comment DataSource="ClinVar" Type="public">Likely benign(2);Uncertain significance(1)</Comment>
                    <DescriptionHistory Dated="2020-05-31">
                        <Description>Likely benign</Description>
                    </DescriptionHistory>
                    <ConditionList>
                        <TraitSet ID="5661" Type="Disease">
                            <Trait ID="492" Type="Disease">
                                <Name>
                                    <ElementValue Type="Alternate">Myopathy, benign congenital, with contractures
                                    </ElementValue>
                                </Name>
                                <Name>
                                    <ElementValue Type="Alternate">Muscular dystrophy, benign congenital</ElementValue>
                                </Name>
                                <Name>
                                    <ElementValue Type="Preferred">Bethlem myopathy 1</ElementValue>
                                </Name>
                                <Name>
                                    <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT
                                        5
                                    </ElementValue>
                                    <XRef Type="MIM" ID="158810" DB="OMIM"/>
                                </Name>
                                <Symbol>
                                    <ElementValue Type="Preferred">BTHLM1</ElementValue>
                                    <XRef Type="MIM" ID="158810" DB="OMIM"/>
                                </Symbol>
                                <Symbol>
                                    <ElementValue Type="Alternate">LGMDD5</ElementValue>
                                    <XRef Type="MIM" ID="158810" DB="OMIM"/>
                                </Symbol>
                                <AttributeSet>
                                    <Attribute Type="public definition">Collagen type VI-related disorders represent a
                                        continuum of overlapping phenotypes with Bethlem myopathy at the mild end,
                                        Ullrich congenital muscular dystrophy (CMD) at the severe end, and two rare,
                                        less well-defined disorders – autosomal dominant limb-girdle muscular dystrophy
                                        and autosomal recessive myosclerosis myopathy – in between. Although Bethlem
                                        myopathy and Ullrich CMD were defined long before their molecular basis was
                                        known, they remain useful for clarification of prognosis and management. Bethlem
                                        myopathy, characterized by the combination of proximal muscle weakness and
                                        variable contractures, affects most frequently the long finger flexors, elbows,
                                        and ankles. Onset may be prenatal (characterized by decreased fetal movements),
                                        neonatal (hypotonia or torticollis), in early childhood (delayed motor
                                        milestones, muscle weakness, and contractures), or in adulthood (proximal
                                        weakness and Achilles tendon or long finger flexor contractures). Because of
                                        slow progression, more than two thirds of affected individuals over age 50 years
                                        rely on supportive means for outdoor mobility. Respiratory involvement is rare
                                        and appears to be related to more severe muscle weakness in later life. Ullrich
                                        CMD is characterized by congenital weakness and hypotonia, proximal joint
                                        contractures, and striking hyperlaxity of distal joints. Some affected children
                                        acquire the ability to walk independently; however, progression of the disease
                                        often results in later loss of ambulation. Early and severe respiratory
                                        involvement may require ventilatory support in the first or second decade of
                                        life.
                                    </Attribute>
                                    <XRef ID="NBK1503" DB="GeneReviews"/>
                                </AttributeSet>
                                <Citation Type="review" Abbrev="GeneReviews">
                                    <ID Source="PubMed">20301676</ID>
                                    <ID Source="BookShelf">NBK1503</ID>
                                </Citation>
                                <Citation Type="practice guideline" Abbrev="Int'l SCC for CMD, 2010">
                                    <ID Source="PubMed">21078917</ID>
                                </Citation>
                                <Citation Type="review" Abbrev="GeneReviews">
                                    <ID Source="PubMed">20301468</ID>
                                    <ID Source="BookShelf">NBK1291</ID>
                                </Citation>
                                <XRef ID="610" DB="Orphanet"/>
                                <XRef ID="CN029274" DB="MedGen"/>
                                <XRef ID="MONDO:0024530" DB="MONDO"/>
                                <XRef Type="MIM" ID="158810" DB="OMIM"/>
                            </Trait>
                        </TraitSet>
                        <TraitSet ID="7429" Type="Disease">
                            <Trait ID="16600" Type="Disease">
                                <Name>
                                    <ElementValue Type="Preferred">Collagen VI-related myopathy</ElementValue>
                                    <XRef ID="Collagen+VI-related+myopathy/8002" DB="Genetic Alliance"/>
                                </Name>
                                <Name>
                                    <ElementValue Type="Alternate">Collagen 6-related myopathy</ElementValue>
                                </Name>
                                <Symbol>
                                    <ElementValue Type="Preferred">COL6-RM</ElementValue>
                                </Symbol>
                                <AttributeSet>
                                    <Attribute Type="public definition">Collagen type VI-related disorders represent a
                                        continuum of overlapping phenotypes with Bethlem myopathy at the mild end,
                                        Ullrich congenital muscular dystrophy (CMD) at the severe end, and two rare,
                                        less well-defined disorders – autosomal dominant limb-girdle muscular dystrophy
                                        and autosomal recessive myosclerosis myopathy – in between. Although Bethlem
                                        myopathy and Ullrich CMD were defined long before their molecular basis was
                                        known, they remain useful for clarification of prognosis and management. Bethlem
                                        myopathy, characterized by the combination of proximal muscle weakness and
                                        variable contractures, affects most frequently the long finger flexors, elbows,
                                        and ankles. Onset may be prenatal (characterized by decreased fetal movements),
                                        neonatal (hypotonia or torticollis), in early childhood (delayed motor
                                        milestones, muscle weakness, and contractures), or in adulthood (proximal
                                        weakness and Achilles tendon or long finger flexor contractures). Because of
                                        slow progression, more than two thirds of affected individuals over age 50 years
                                        rely on supportive means for outdoor mobility. Respiratory involvement is rare
                                        and appears to be related to more severe muscle weakness in later life. Ullrich
                                        CMD is characterized by congenital weakness and hypotonia, proximal joint
                                        contractures, and striking hyperlaxity of distal joints. Some affected children
                                        acquire the ability to walk independently; however, progression of the disease
                                        often results in later loss of ambulation. Early and severe respiratory
                                        involvement may require ventilatory support in the first or second decade of
                                        life.
                                    </Attribute>
                                    <XRef ID="NBK1503" DB="GeneReviews"/>
                                </AttributeSet>
                                <Citation Type="review" Abbrev="GeneReviews">
                                    <ID Source="PubMed">20301676</ID>
                                    <ID Source="BookShelf">NBK1503</ID>
                                </Citation>
                                <XRef ID="CN117976" DB="MedGen"/>
                            </Trait>
                        </TraitSet>
                        <TraitSet ID="9590" Type="Disease">
                            <Trait ID="16789" Type="Disease">
                                <Name>
                                    <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
                                </Name>
                                <Name>
                                    <ElementValue Type="Preferred">not specified</ElementValue>
                                </Name>
                                <AttributeSet>
                                    <Attribute Type="public definition">The term 'not specified' was created for use in
                                        ClinVar so that submitters can convey the concept that a variant is benign,
                                        likely benign, or of uncertain significance for an unspecified set of disorders.
                                        This usage was introduced in 2014 to replace AllHighlyPenetrant.
                                    </Attribute>
                                </AttributeSet>
                                <XRef ID="CN169374" DB="MedGen"/>
                            </Trait>
                        </TraitSet>
                    </ConditionList>
                </Interpretation>
            </Interpretations>
            <ClinicalAssertionList>
                <ClinicalAssertion ID="1403880" DateCreated="2018-04-04" DateLastUpdated="2019-03-31"
                                   SubmissionDate="2018-03-26">
                    <ClinVarSubmissionID localKey="GDX:1784188|Not Provided" submittedAssembly="GRCh37"/>
                    <ClinVarAccession Accession="SCV000722725" Type="SCV" Version="1" SubmitterName="GeneDx"
                                      OrgID="26957" OrganizationCategory="laboratory"/>
                    <RecordStatus>current</RecordStatus>
                    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                    <Interpretation DateLastEvaluated="2017-09-11">
                        <Description>Likely benign</Description>
                        <Comment Type="public">This variant is considered likely benign or benign based on one or more
                            of the following criteria: it is a conservative change, it occurs at a poorly conserved
                            position in the protein, it is predicted to be benign by multiple in silico algorithms,
                            and/or has population frequency not consistent with disease.
                        </Comment>
                    </Interpretation>
                    <Assertion>variation to disease</Assertion>
                    <AttributeSet>
                        <Attribute Type="AssertionMethod">GeneDX Variant Classification (06012015)</Attribute>
                        <Citation>
                            <URL>
                                https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf
                            </URL>
                        </Citation>
                    </AttributeSet>
                    <ObservedInList>
                        <ObservedIn>
                            <Sample>
                                <Origin>germline</Origin>
                                <Species TaxonomyId="9606">human</Species>
                                <AffectedStatus>yes</AffectedStatus>
                            </Sample>
                            <Method>
                                <MethodType>clinical testing</MethodType>
                            </Method>
                            <ObservedData>
                                <Attribute Type="Description">not provided</Attribute>
                            </ObservedData>
                        </ObservedIn>
                    </ObservedInList>
                    <SimpleAllele>
                        <GeneList>
                            <Gene Symbol="COL6A2"/>
                        </GeneList>
                        <VariantType>Variation</VariantType>
                        <Location>
                            <SequenceLocation Assembly="GRCh37" Chr="21" alternateAllele="A" referenceAllele="G"
                                              start="47552103" stop="47552103" variantLength="1"/>
                        </Location>
                        <AttributeSet>
                            <Attribute Type="HGVS">NM_001849.3:c.2697G&gt;A</Attribute>
                        </AttributeSet>
                    </SimpleAllele>
                    <TraitSet Type="Disease">
                        <Trait Type="Disease">
                            <Name>
                                <ElementValue Type="Preferred">not specified</ElementValue>
                            </Name>
                        </Trait>
                    </TraitSet>
                    <SubmissionNameList>
                        <SubmissionName>SUB3839901</SubmissionName>
                    </SubmissionNameList>
                </ClinicalAssertion>
                <ClinicalAssertion ID="1255376" DateCreated="2017-12-20" DateLastUpdated="2020-05-05"
                                   SubmissionDate="2020-01-29">
                    <ClinVarSubmissionID localKey="1519820|MedGen:CN029274" submittedAssembly="GRCh37"/>
                    <ClinVarAccession Accession="SCV000657167" Type="SCV" Version="3" SubmitterName="Invitae"
                                      OrgID="500031" OrganizationCategory="laboratory"/>
                    <RecordStatus>current</RecordStatus>
                    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                    <Interpretation DateLastEvaluated="2019-12-31">
                        <Description>Likely benign</Description>
                    </Interpretation>
                    <Assertion>variation to disease</Assertion>
                    <AttributeSet>
                        <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
                        <Citation>
                            <ID Source="PubMed">28492532</ID>
                        </Citation>
                    </AttributeSet>
                    <ObservedInList>
                        <ObservedIn>
                            <Sample>
                                <Origin>germline</Origin>
                                <Species TaxonomyId="9606">human</Species>
                                <AffectedStatus>unknown</AffectedStatus>
                            </Sample>
                            <Method>
                                <MethodType>clinical testing</MethodType>
                            </Method>
                            <ObservedData>
                                <Attribute Type="Description">not provided</Attribute>
                            </ObservedData>
                        </ObservedIn>
                    </ObservedInList>
                    <SimpleAllele>
                        <GeneList>
                            <Gene Symbol="COL6A2"/>
                        </GeneList>
                        <VariantType>Variation</VariantType>
                        <AttributeSet>
                            <Attribute Type="HGVS">NM_001849.3:c.2697G&gt;A</Attribute>
                        </AttributeSet>
                    </SimpleAllele>
                    <TraitSet Type="Disease">
                        <Trait Type="Disease">
                            <Name>
                                <ElementValue Type="Preferred">Bethlem myopathy 1</ElementValue>
                            </Name>
                            <XRef DB="MedGen" ID="CN029274" Type="CUI"/>
                        </Trait>
                    </TraitSet>
                    <SubmissionNameList>
                        <SubmissionName>SUB6897608</SubmissionName>
                    </SubmissionNameList>
                </ClinicalAssertion>
                <ClinicalAssertion ID="2530780" DateCreated="2020-05-26" DateLastUpdated="2020-06-01"
                                   SubmissionDate="2020-02-20">
                    <ClinVarSubmissionID localKey="1414007|MedGen:CN117976" submittedAssembly="GRCh37"/>
                    <ClinVarAccession Accession="SCV001304160" Type="SCV" Version="1"
                                      SubmitterName="Illumina Clinical Services Laboratory,Illumina" OrgID="504895"
                                      OrganizationCategory="laboratory"/>
                    <RecordStatus>current</RecordStatus>
                    <ReviewStatus>criteria provided, single submitter</ReviewStatus>
                    <Interpretation DateLastEvaluated="2018-01-15">
                        <Description>Uncertain significance</Description>
                        <Comment>This variant was observed in the ICSL laboratory as part of a predisposition screen in
                            an ostensibly healthy population. It had not been previously curated by ICSL or reported in
                            the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a
                            candidate for classification through an automated scoring system. Utilizing variant allele
                            frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated
                            score was calculated to assess if this variant is too frequent to cause the disease. Based
                            on the score, this variant could not be ruled out of causing disease and therefore its
                            association with disease required further investigation. A literature search was performed
                            for the gene, cDNA change, and amino acid change (if applicable). No publications were found
                            based on this search. This variant was therefore classified as a variant of unknown
                            significance for this disease.
                        </Comment>
                    </Interpretation>
                    <Assertion>variation to disease</Assertion>
                    <AttributeSet>
                        <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 13 December 2019
                        </Attribute>
                        <Citation>
                            <URL>
                                https://submit.ncbi.nlm.nih.gov/ft/byid/r0x0xrmc/icsl_variant_classification_criteria_13_december_2019.pdf
                            </URL>
                        </Citation>
                    </AttributeSet>
                    <ObservedInList>
                        <ObservedIn>
                            <Sample>
                                <Origin>germline</Origin>
                                <Species TaxonomyId="9606">human</Species>
                                <AffectedStatus>unknown</AffectedStatus>
                            </Sample>
                            <Method>
                                <MethodType>clinical testing</MethodType>
                            </Method>
                            <ObservedData>
                                <Attribute Type="Description">not provided</Attribute>
                            </ObservedData>
                        </ObservedIn>
                    </ObservedInList>
                    <SimpleAllele>
                        <GeneList>
                            <Gene Symbol="COL6A2"/>
                        </GeneList>
                        <VariantType>Variation</VariantType>
                        <Location>
                            <SequenceLocation Assembly="GRCh37" Chr="21" alternateAllele="A" referenceAllele="G"
                                              start="47552103" stop="47552103" variantLength="1"/>
                        </Location>
                        <AttributeSet>
                            <Attribute Type="HGVS">NM_001849.3:c.2697G&gt;A</Attribute>
                        </AttributeSet>
                    </SimpleAllele>
                    <TraitSet Type="Disease">
                        <Trait Type="Disease">
                            <Name>
                                <ElementValue Type="Preferred">Collagen VI-related myopathy</ElementValue>
                            </Name>
                            <XRef DB="MedGen" ID="CN117976" Type="CUI"/>
                        </Trait>
                    </TraitSet>
                    <SubmissionNameList>
                        <SubmissionName>SUB6641900</SubmissionName>
                    </SubmissionNameList>
                </ClinicalAssertion>
            </ClinicalAssertionList>
            <TraitMappingList>
                <TraitMapping ClinicalAssertionID="2530780" TraitType="Disease" MappingType="Name"
                              MappingValue="Collagen VI-related myopathy" MappingRef="Preferred">
                    <MedGen CUI="CN117976" Name="Collagen VI-related myopathy"/>
                </TraitMapping>
                <TraitMapping ClinicalAssertionID="1255376" TraitType="Disease" MappingType="Name"
                              MappingValue="Bethlem myopathy 1" MappingRef="Preferred">
                    <MedGen CUI="CN029274" Name="Bethlem myopathy 1"/>
                </TraitMapping>
                <TraitMapping ClinicalAssertionID="1403880" TraitType="Disease" MappingType="Name"
                              MappingValue="not specified" MappingRef="Preferred">
                    <MedGen CUI="CN169374" Name="not specified"/>
                </TraitMapping>
            </TraitMappingList>
        </InterpretedRecord>
    </VariationArchive>
</ClinVarVariationRelease>